CME Group Inc. Files 8-K Report

Ticker: CME · Form: 8-K · Filed: 2025-03-10T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financials, filing

Related Tickers: CME

TL;DR

CME Group filed an 8-K on 3/10/25 for a material agreement & financials.

AI Summary

On March 10, 2025, CME Group Inc. filed an 8-K report, indicating the entry into a material definitive agreement and the filing of financial statements and exhibits. The filing does not specify the details of the agreement or the nature of the financial statements.

Why It Matters

This filing signals a significant event for CME Group Inc., potentially involving a new material agreement or updated financial information that could impact investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not contain specific negative or positive financial information that would immediately indicate high risk.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by CME Group Inc. on or before March 10, 2025?

The provided filing excerpt does not specify the details of the material definitive agreement.

What financial statements and exhibits are being filed with this 8-K report?

The filing excerpt indicates that financial statements and exhibits are being filed, but their specific content is not detailed.

What is the exact date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is March 10, 2025.

What is CME Group Inc.'s principal executive office address?

CME Group Inc.'s principal executive office is located at 20 South Wacker Drive, Chicago, Illinois 60606.

Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?

This 8-K report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

From the Filing

0001193125-25-050881.txt : 20250310 0001193125-25-050881.hdr.sgml : 20250310 20250310161249 ACCESSION NUMBER: 0001193125-25-050881 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250310 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250310 DATE AS OF CHANGE: 20250310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 09 Crypto Assets IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 25723823 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d921384d8k.htm 8-K 8-K Illinois       false 0001156375 0001156375 2025-03-10 2025-03-10     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2025     CME GROUP INC. (Exact name of registrant as specified in its charter)       Delaware   001-31553   36-4459170 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   20 South Wacker Drive   Chicago          Illinois           60606 (Address of Principal Executive Offices)        (Zip Code) Registrant’s telephone number, including area code: (312) 930-1000 N/A (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock   CME   Nasdaq Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01 Entry into a Material Definitive Agreement. On March 10, 2025, CME Group Inc. (the “Company”) completed its previously announced public offering of $750,000,000 aggregate principal amount of 4.400% Notes due 2030 (the “Notes”). The Notes were offered by the Company pursuant to its automatic shelf registration statement on Form S-3 (File No. 333-285481) and the

View on Read The Filing